Drug interactions are actually the greatest impediment in dealing with HIV/HCV co-contaminated people. When it comes to security outcomes, tenofovir DF used with ledipasvir or velpatasvir can cause a rise in serum creatinine, specially when coupled with a pharmacokinetic booster. [139] The use of tenofovir DF really should be avoided in these condi